Effects of early recombinant human growth hormone treatment in young Chinese children with Prader–Willi syndrome

BACKGROUND: Prader–Willi syndrome (PWS) is a rare and multisystemic genetic disorder that is characterized by severe hypotonia, hyperphagia, short stature, and global developmental delay. Although early recombinant human growth hormone (rhGH) treatment has been proven to rescue some symptoms and bri...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Ying, Yang, Li-Li, Dai, Yang-Li, Shen, Zheng, Zhou, Qiong, Zou, Chao-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906936/
https://www.ncbi.nlm.nih.gov/pubmed/36750945
http://dx.doi.org/10.1186/s13023-023-02615-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906936/
https://www.ncbi.nlm.nih.gov/pubmed/36750945
http://dx.doi.org/10.1186/s13023-023-02615-7

Ejemplares similares